You are here

Home

Cancer/Tumor

CR2Cancer

Submitted by ChenLiang on Tue, 01/09/2018 - 17:43

Chromatin regulators (CRs) can dynamically modulate chromatin architecture to epigenetically regulate gene expression in response to intrinsic and extrinsic signalling cues. Somatic alterations or misexpression of CRs might reprogram the epigenomic landscape of chromatin, which in turn lead to a wide range of common diseases, notably cancer. Here, we present CR2Cancer, a comprehensive annotation and visualization database for CRs in human cancer constructed by high throughput data analysis and literature mining.

Rating: 
Give CR2Cancer 1/5
Give CR2Cancer 2/5
Give CR2Cancer 3/5
Give CR2Cancer 4/5
Give CR2Cancer 5/5
Average: 5 (1 vote)

BCCTBbp

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

BCCTBbp (http://bioinformatics.breastcancertissuebank.org) was initially developed as the data-mining portal of the Breast Cancer Campaign Tissue Bank (BCCTB), a vital resource of breast cancer tissue for researchers to support and promote cutting-edge research.

Rating: 
Give BCCTBbp 1/5
Give BCCTBbp 2/5
Give BCCTBbp 3/5
Give BCCTBbp 4/5
Give BCCTBbp 5/5
Average: 5 (1 vote)

UFFizi

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Feature selection is an important pre-processing task in the analysis of complex data. Selecting an appropriate subset of features can improve classification or clustering and lead to better understanding of the data. An important example is that of finding an informative group of genes out of thousands that appear in gene-expression analysis. Numerous supervised methods have been suggested but only a few unsupervised ones exist.

Rating: 
Give UFFizi 1/5
Give UFFizi 2/5
Give UFFizi 3/5
Give UFFizi 4/5
Give UFFizi 5/5
Average: 5 (1 vote)

miRpower

Submitted by ChenLiang on Fri, 10/21/2016 - 16:39

PURPOSE: The proper validation of prognostic biomarkers is an important clinical issue in breast cancer research. MicroRNAs (miRNAs) have emerged as a new class of promising breast cancer biomarkers. In the present work, we developed an integrated online bioinformatic tool to validate the prognostic relevance of miRNAs in breast cancer. METHODS: A database was set up by searching the GEO, EGA, TCGA, and PubMed repositories to identify datasets with published miRNA expression and clinical data.

Rating: 
Give miRpower 1/5
Give miRpower 2/5
Give miRpower 3/5
Give miRpower 4/5
Give miRpower 5/5
Average: 5 (1 vote)

Pages

Subscribe to Cancer/Tumor